Search results for "Open"

showing 10 items of 3963 documents

Soccer players have a better standing balance in nondominant one-legged stance

2010

Rosario Barone1, Filippo Macaluso2, Marcello Traina3,4, Vincenza Leonardi4,5, Felicia Farina1, Valentina Di Felice11Human Anatomy Section 'E. Luna', BioNeC, University of Palermo, Palermo, Italy; 2Department of Physiological Science, Stellenbosch University, Stellenbosch, South Africa; 3Department of Internal Medicine, Cardiovascular and Renal Diseases, 4Methods and Didactics of Motory Activities, DISMOT, 5Department of General Surgery, Emergency and Organ Transplants (GENURTO), University of Palermo, Palermo, Italy  Rosario Barone and Filippo Macaluso contributed equally to the workAbstract: The purpose of this study was to analyze the differences in standing balan…

medicine.medical_specialtyBasketballsport practicebusiness.industryMean valueBody sway bipedal stance center of pressure sport practice.Body swayStanding balanceCenter of pressure (terrestrial locomotion)center of pressureClosed eyesSedentary groupPhysical therapymedicinebipedal stancebody swaybusinessOpen Access Journal of Sports Medicinehuman activitiesSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieOriginal Research
researchProduct

Bone Mineral Density and Bone Metabolism in Diabetes Mellitus

1998

The effect of diabetes mellitus on bone metabolism and bone mineral density is discussed controversially. Diabetes mellitus due to an autoimmune process seems to be associated with low turnover osteopenia either in the animal model or in children and adolescents. A number of factors are discussed as being involved, but in this age group clinical symptoms are missing. Adult patients of either sex with IDDM show a reduced bone mineral density when measured at peripheral sites such as the distal forearm or the femoral neck, diabetic complications such as neuropathy and microangiopathy seem to pronounce the deficit of bone mass. In these patients, osteopenia is accompanied by a high turnover si…

medicine.medical_specialtyBone densityEndocrinology Diabetes and MetabolismClinical BiochemistryOverweightBiochemistryBone and BonesBone remodelingEndocrinologyBone DensityDiabetes mellitusInternal medicinemedicineAnimalsHumansRats Inbred BBFemoral neckBone mineralbusiness.industryBiochemistry (medical)MicroangiopathyGeneral Medicinemedicine.diseaseRatsOsteopeniaDiabetes Mellitus Type 1Endocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2Osteoporosismedicine.symptombusinessHormone and Metabolic Research
researchProduct

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

2016

Objective: To provide meta-analytical evidence of bone mineral density (BMD), fractures, and osteoporosis rates in eating disorders (ED) vs. healthy controls (HCs). Method: Three independent authors searched major electronic databases from inception till August 2015 for cross-sectional studies reporting BMD in people with ED (anorexia nervosa, (AN); bulimia nervosa, (BN); eating disorders not otherwise specified, (EDNOS)) vs. HCs. Standardized mean differences (SMDs) ±95% and confidence intervals (CIs) were calculated for BMD, and odds ratios (ORs) for osteopenia, osteoporosis, and fractures. Results: Overall, 57 studies were eligible, including 21 607 participants (ED = 6485, HCs = 15 122)…

medicine.medical_specialtyBone densityOsteoporosis030209 endocrinology & metabolismComorbidityFeeding and Eating Disorderseating disorders (ED)Fractures Bone03 medical and health sciences0302 clinical medicineBone DensityInternal medicinemedicineHumans030212 general & internal medicineFemoral neckBulimia nervosabusiness.industryAnorexia nervosaOdds ratiomedicine.diseaseOsteopeniaPsychiatry and Mental healthEating disordersmedicine.anatomical_structureBulimia nervosaosteoporosis rateEating disordersPhysical therapyOsteoporosisAmenorrheamedicine.symptomAnorexia nervosa; Bone density; Bulimia nervosa; Eating disorders; Fractures; Psychiatry and Mental Healthbusinessmeta-analytical evidence of bonemineral density (BMD)Fracturesanorexia nervosa; bone density; bulimia nervosa; eating disorders; fracturesActa Psychiatrica Scandinavica
researchProduct

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

2021

ObjectiveThe benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA administration.DesignWe pooled the data of 977 consecutive patients from 21 studies of HCV-related cirrhosis and HCC, who achieved complete radiological response after surgical/locoregional treatments and received DAAs (DAA group). Recurrence or death risk was expressed as HCC recurrence or death per 100 person-years (100PY). Propensity score-matched patients from the ITA.LI.CA. cohort (n=328) served as DAA-unexposed controls (no-DAA group). Risk fac…

medicine.medical_specialtyCarcinoma HepatocellularCirrhosisAntiviral AgentsGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineantiviral therapymedicineHumansPropensity Scoreantiviral therapy; hepatocellular carcinoma; meta-analysisbusiness.industryLiver NeoplasmsGastroenterologyAntiviral therapyPatient datahepatocellular carcinomamedicine.disease3. Good healthmeta-analysis030220 oncology & carcinogenesisMeta-analysisHepatocellular carcinomaRelative riskCohort030211 gastroenterology & hepatology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieNeoplasm Recurrence LocalbusinessDirect acting
researchProduct

Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study

2021

Summary Background Trans-arterial chemoembolization (TACE) is one first-line option therapy for patients with hepatocellular carcinoma (HCC) not suitable for surgical resection. Aims We evaluated the effects of sunitinib plus doxorubicin-TACE on bleeding or liver failure. Methods Seventy-eight patients with HCC were included in this randomized, double-blind study. They received one to three TACE plus either sunitinib or placebo four weeks out of six for one year. The occurrence of severe bleeding or liver failure was assessed during the week after the TACE. The safety and survival outcomes were evaluated. Results No bleeding complication was reported. One and two liver failures were respect…

medicine.medical_specialtyCarcinoma HepatocellularNeutropeniaurologic and male genital diseasesPlaceboPlacebo groupGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineSunitinibmedicineHumansChemoembolization TherapeuticHepatologybusiness.industrySunitinibLiver NeoplasmsGastroenterologyLiver failuremedicine.diseaseAcute toxicityTreatment Outcome030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyDose reductionbusinessLiver Failuremedicine.drugClinics and Research in Hepatology and Gastroenterology
researchProduct

Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

2022

Abstract Background An enhanced surveillance schedule has been proposed for cirrhotics with viral etiology, who are considered at extremely high-risk of hepatocellular carcinoma (HCC). Aims We compared the 3- and 6-months surveillance interval, evaluating cancer stage at diagnosis and patient survival. Methods Data of 777 HBV and HCV cirrhotic patients with HCC diagnosed under a 3-months (n = 109, 3MS group) or a 6-months (n = 668, 6MS group) surveillance were retrieved from the Italian Liver Cancer database. Survival in the 3MS group was considered as observed and adjusted for lead-time bias, and survival analysis was repeated after a propensity score matching. Results The 3-months surveil…

medicine.medical_specialtyCarcinoma HepatocellularSurvivalHepatocellular carcinomaCancer stageCancer stage; Hepatocellular carcinoma; Surveillance interval; SurvivalInternal medicinemedicineHumansPropensity ScoreSurveillance intervalSurvival analysisHigh risk patientsHepatologybusiness.industryCancer stageLiver NeoplasmsSettore MED/09 - MEDICINA INTERNAGastroenterologyPatient survivalmedicine.diseaseSurvival AnalysisHepatocellular carcinomaPropensity score matchingSurvival AnalysiLiver cancerbusinessMedian survivalHuman
researchProduct

A Phase 2 Trial of Ixabepilone in Asian Patients with Advanced Gastric Cancer Previously Treated with Fluoropyrimidine-Based Chemotherapy

2012

ABSTRACT Background The highest rates of gastric cancer occur in Eastern Asia. Fluoropyrimidine-based therapy is used initially in unresectable and metastatic disease, following progression, 60–70% of patients in Asian countries subsequently receive second-line chemotherapy. However, there is no standard treatment in this setting. Ixabepilone, an epothilone B analog, is a non-taxane microtubule-stabilizing agent with clinical anti-tumor activity across multiple tumor types. We evaluated the efficacy and safety of single-agent ixabepilone as a second-line chemotherapy in Asian patients. Methods Asian patients with unresectable or metastatic gastric adenocarcinoma who had failed previous fluo…

medicine.medical_specialtyChemotherapybusiness.industryStandard treatmentmedicine.medical_treatmentIxabepiloneCancerHematologyNeutropeniamedicine.diseaseGastroenterologychemistry.chemical_compoundOncologychemistryStatistical significanceInternal medicineClinical endpointMedicinebusinessFebrile neutropeniaAnnals of Oncology
researchProduct

Determination of Death in Execution by Lethal Injection in China.

2018

Abstract:Since 1997, execution in China has been increasingly performed by lethal injection. The current criteria for determination of death for execution by lethal injection (cessation of heartbeat, cessation of respiration, and dilated pupils) neither conform to current medical science nor to any standard of medical ethics. In practice, death is pronounced in China within tens of seconds after starting the lethal injection. At this stage, however, neither the common criteria for cardiopulmonary death (irreversible cessation of heartbeat and breathing) nor that of brain death (irreversible cessation of brain functions) have been met. To declare a still-living person dead is incompatible wi…

medicine.medical_specialtyChinaHealth (social science)Insufficient AnesthesiaTissue and Organ ProcurementHeartbeatLevel data030230 surgery0603 philosophy ethics and religionOrgan transplantation03 medical and health sciences0302 clinical medicineLethal InjectionmedicineHumansEthics MedicalSurgical anesthesiaThiopentalCapital Punishmentbusiness.industryHealth Policy06 humanities and the artsPostmortem bloodUnited StatesDeathIssues ethics and legal aspectsOrgan procurementAnesthesiaInjections Intravenous060301 applied ethicsbusinessCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees
researchProduct

Primary Biliary Cholangitis: advances in management and treatment of the disease

2017

Primary Biliary Cholangitis, previously known as Primary Biliary Cirrhosis, is a rare disease, which mainly affects women in their fifth to seventh decades of life. It is a chronic autoimmune disease characterized by a progressive damage of interlobular bile ducts leading to ductopenia, chronic cholestasis and bile acids retention. Even if the disease usually presents a long asymptomatic phase and a slow progression, in many patients it may progress faster toward cirrhosis and its complications. The 10Â year mortality is greater than in diseases such as human immunodeficiency virus/Hepatitis C Virus coinfection and breast cancer. Ursodeoxycholic acid is the only treatment available today, b…

medicine.medical_specialtyCholagogues and CholereticsCirrhosisPrimary Biliary CholangitisCholangitisDiseaseChenodeoxycholic AcidGastroenterologyEnd Stage Liver Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisDuctopeniaAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acid; Hepatology; GastroenterologyMED/12 - GASTROENTEROLOGIAInternal medicineAlkaline phosphatasemedicineHumansFibrateSettore SECS-P/01 - Economia PoliticaBudesonideCholestasisHepatologyAlkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acidbusiness.industryGastroenterologyObeticholic acidHepatologymedicine.diseaseUrsodeoxycholic acidchemistryUrsodeoxycholic acid030220 oncology & carcinogenesisObeticholic acidDisease Progression030211 gastroenterology & hepatologyDrug Therapy CombinationbusinessFibratesbiologicalRare diseasemedicine.drug
researchProduct

Frailty and Sarcopenia in Acute‐on‐Chronic Liver Failure

2021

In patients with cirrhosis, sarcopenia is a critical reduction in skeletal muscle mass and frailty represents a status of global physical dysfunction caused by under nutrition, muscle wasting, and functional impairment. Both are prevalent conditions in liver transplant candidates and have shown to be independent predictors of adverse outcome. Evidence supports their incorporation into clinical practice both as a prognostic factor guiding clinical decision making and as a tool to identify candidates for physical and nutritional interventions. The wide heterogeneity of instruments used for sarcopenia and frailty measurement, the absence of a single suitable instrument for sarcopenia and frail…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryRC799-869ReviewDiseases of the digestive system. Gastroenterologymedicine.diseaseFrailty assessmentUnder nutritionTransplantationSarcopeniamedicineAcute on chronic liver failureIn patientmedicine.symptomIntensive care medicinebusinessWastingHepatology Communications
researchProduct